News about Clinical Trials

Vascarta's Curcumin Gel Shows Promising Results in Reducing Osteoarthritis Knee Pain

Clinical trial findings reveal significant pain reduction and strong safety profile for investigational topical gel VAS-101 in adults with knee osteoarthritis.

Clinical Trials | 02/04/2026 | By News Bureau |  529

AskBio Completes Enrollment for Phase 2 Gene Therapy Trial Targeting Heart Failure

The GenePHIT study evaluating investigational therapy AB-1002 for heart failure with reduced ejection fraction has fully enrolled 173 patients, with initial results expected in early 2027.

Clinical Trials | 02/04/2026 | By News Bureau |  111

Alltrna Receives Approval to Begin First-in-Human Trial of tRNA Therapeutic AP003

Alltrna initiates first-in-human trial of engineered tRNA therapy AP003 in Australia, marking a breakthrough in genetic disease treatment.

Clinical Trials | 01/04/2026 | By News Bureau |  286

AviadoBio Advances AVB-101, Starts New Cohort in Phase 1/2 ASPIRE-FTD Trial

AviadoBio advances AVB-101 gene therapy with a new Phase 1/2 ASPIRE-FTD cohort, reporting encouraging early data, securing strategic funding and regaining full programme rights.

Clinical Trials | 01/04/2026 | By News Bureau |  107

Arletta Pharma Reports Positive Phase II Results for Lybrido in Female Sexual Arousal Disorder

Study shows significant improvement in physiological arousal markers, supporting further development of testosterone-sildenafil combination therapy for FSIAD.

Clinical Trials | 30/03/2026 | By News Bureau |  108

Bristol Myers Squibb Reports Positive Phase 3 SCOUT-HCM Trial Results

Bristol Myers Squibb reports positive Phase 3 SCOUT-HCM results showing Camzyos efficacy and safety in adolescents with oHCM, achieving significant LVOT reduction with no new safety concerns.

Clinical Trials | 30/03/2026 | By News Bureau |  130

Hope Medicine Reports Positive Phase II Results for First-in-Class Endometriosis Drug

HMI-115 shows significant pain reduction without hormonal disruption, paving the way for global phase III trials.

Clinical Trials | 26/03/2026 | By News Bureau |  238

IMUNON Reports Phase 2 Data Showing Improved Survival in Advanced Ovarian Cancer

IMUNON reports updated Phase 2 data showing improved Overall Survival (OS) with IMNN-001 in advanced ovarian cancer.

Clinical Trials | 26/03/2026 | By News Bureau |  109

Ministry of Ayush and DBT Launch Clinical Study on Ayurveda for TB Treatment

Ministry of Ayush and DBT launch a clinical study on Ayurveda as adjunct therapy for tuberculosis (TB), advancing evidence-based, integrative approaches to strengthen India’s TB elimination efforts.

Clinical Trials | 25/03/2026 | By News Bureau |  109

Arch Biopartners Advances Phase II Trial of LSALT Peptide as New Site Begins Patient Dosing

Arch Biopartners advances LSALT peptide trial for acute kidney injury as new clinical site initiates patient dosing and global expansion plans progress.

Clinical Trials | 24/03/2026 | By News Bureau